SANTA CLARA, Calif. -- Agilent Technologies Inc. (NYSE: A) today introduced Agilent CytoGenomics 1.5 software. This analytical tool gives researchers the ability to streamline their analysis by querying the in-house CytoGenomic database and external databases. The software is designed for easy data interpretation and simple report generation.
Agilent provides the most accepted microarray platform for cytogenetics, and the new software highlights Agilent's commitment to providing complete solutions for cytogenetic research. These solutions include CGH+SNP microarrays for determining copy number changes and copy neutral aberrations on the same chip, DNA labeling kits, microarray scanners and automation platforms. Agilent CytoGenomics 1.5 was developed to help customers exploit the performance of the arrays, maximize throughput, and complete their CGH and CGH + SNP workflows.
'Cytogeneticists need to quickly and confidently gain insight into the biology of their samples,' said Robert Schueren, Agilent vice president, Genomics. 'We developed this new software to make the process faster and easier, complementing a complete set of solutions for cytogenetic researchers.'
For more information, visit www.agilent.com/genomics/cyto_software.
About Agilent Technologies
Agilent Technologies Inc. (NYSE: A) is the world's premier measurement company and a technology leader in chemical analysis, life sciences, electronics and communications. The company's 18,500 employees serve customers in more than 100 countries. Agilent had net revenues of $5.4 billion in fiscal 2010. Information about Agilent is available at www.agilent.com.